Anika Therapeutics (ANIK) Income from Discontinued Operations (2024 - 2025)
Anika Therapeutics' (ANIK) quarterly Income from Discontinued Operations came in at -$1.5 million in Q4 2025, up 92.21% year-over-year from -$785065.7 in Q4 2024, and down 278.37% quarter-over-quarter from $846000.0 in Q3 2025.
Analysis
Anika Therapeutics (ANIK) Income from Discontinued Operations (2024 - 2025) Analysis & Trends
Anika Therapeutics (ANIK) has reported Income from Discontinued Operations for 2 consecutive years, with -$1.5 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Income from Discontinued Operations rose 92.21% year-over-year to -$1.5 million in Q4 2025; TTM through Jun 2026 was -$663000.0, a 98.61% increase from a year earlier, with the FY2025 full-year figure at -$901000.0, up 98.11% from the prior year.
- Income from Discontinued Operations was -$1.5 million for Q4 2025 at Anika Therapeutics, down from $846000.0 in the prior quarter.
- Over five years, Income from Discontinued Operations peaked at $2.5 million in Q2 2024 and troughed at -$28.1 million in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Anika Therapeutics | 277.93 Mn | 239.52 Mn | 21.24 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -1.51 Mn |
| Sep 30, 2025 | 846,000.00 |
| Jun 30, 2025 | 677,000.00 |
| Mar 31, 2025 | -915,000.00 |
| Dec 31, 2024 | -19.38 Mn |
| Sep 30, 2024 | -28.07 Mn |
| Jun 30, 2024 | 2.45 Mn |
| Mar 31, 2024 | -2.56 Mn |